Robert Glenning

Insider Reports History

Entity
Individual
Location
C/O Eagle Pharmaceuticals, Inc., 50 Tice Blvd Suite 315, Woodcliff Lake, NJ
Signature
/s/ Scott Tarriff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Glenning:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EAGLE PHARMACEUTICALS, INC. Director Stock Option (right to buy) 16.3K Mar 7, 2023 Direct

Insider Reports Filed by Robert Glenning

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EGRX EAGLE PHARMACEUTICALS, INC. Mar 7, 2023 1 $0 4 Mar 9, 2023 Director
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2022 1 $0 4 Mar 2, 2022 Director